NO942695D0 - Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament - Google Patents

Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament

Info

Publication number
NO942695D0
NO942695D0 NO942695A NO942695A NO942695D0 NO 942695 D0 NO942695 D0 NO 942695D0 NO 942695 A NO942695 A NO 942695A NO 942695 A NO942695 A NO 942695A NO 942695 D0 NO942695 D0 NO 942695D0
Authority
NO
Norway
Prior art keywords
preparation
loweralkyl
pyridinyl
indole
amines
Prior art date
Application number
NO942695A
Other languages
English (en)
Other versions
NO306597B1 (no
NO942695L (no
Inventor
Sathapana Kongsamut
Craig Paul Smith
Ann Theresa Woods
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO942695D0 publication Critical patent/NO942695D0/no
Publication of NO942695L publication Critical patent/NO942695L/no
Publication of NO306597B1 publication Critical patent/NO306597B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO942695A 1993-07-19 1994-07-18 Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament NO306597B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/092,848 US5356910A (en) 1993-07-19 1993-07-19 Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Publications (3)

Publication Number Publication Date
NO942695D0 true NO942695D0 (no) 1994-07-18
NO942695L NO942695L (no) 1995-01-20
NO306597B1 NO306597B1 (no) 1999-11-29

Family

ID=22235450

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942695A NO306597B1 (no) 1993-07-19 1994-07-18 Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament

Country Status (21)

Country Link
US (1) US5356910A (no)
EP (1) EP0635269B1 (no)
JP (1) JP2807633B2 (no)
KR (1) KR100325276B1 (no)
AT (1) ATE186215T1 (no)
AU (1) AU673747B2 (no)
CA (1) CA2128312C (no)
CZ (1) CZ288593B6 (no)
DE (1) DE69421457T2 (no)
DK (1) DK0635269T3 (no)
EG (1) EG20716A (no)
ES (1) ES2138017T3 (no)
GR (1) GR3032292T3 (no)
HU (1) HU217063B (no)
MX (1) MX9405209A (no)
NO (1) NO306597B1 (no)
NZ (1) NZ264015A (no)
PL (1) PL304335A1 (no)
RU (1) RU2164795C2 (no)
TW (1) TW349864B (no)
ZA (1) ZA945236B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
EP0840609B1 (en) * 1995-07-27 2002-06-05 Aventis Pharmaceuticals Inc. Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
HUP9802413A3 (en) * 1995-07-27 2002-02-28 Aventis Pharmaceuticals Inc Br Use of n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents and for the preparation of a pharmaceutical composition for the treatment of convulsions
JP4608723B2 (ja) * 1999-03-10 2011-01-12 東ソー株式会社 置換インドール誘導体の製造方法
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2892021B1 (fr) * 2005-10-19 2008-01-04 Urogene Traitement de l'incontinence urinaire d'effort et mixte
FR2892022B1 (fr) * 2005-10-19 2008-01-04 Urogene Sa Traitement des symptomes de l'irritation de la vessie
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
ATE115143T1 (de) * 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5214038A (en) * 1991-04-15 1993-05-25 Hoechst-Roussel Pharmaceuticals Inc. 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5185350A (en) 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles

Also Published As

Publication number Publication date
CA2128312C (en) 2004-09-28
NZ264015A (en) 1997-07-27
TW349864B (en) 1999-01-11
CZ173094A3 (en) 1995-02-15
CA2128312A1 (en) 1995-01-20
EP0635269A1 (en) 1995-01-25
GR3032292T3 (en) 2000-04-27
EG20716A (en) 1999-12-29
HUT69709A (en) 1995-09-28
KR950002761A (ko) 1995-02-16
JP2807633B2 (ja) 1998-10-08
HU217063B (hu) 1999-11-29
AU6753194A (en) 1995-01-27
PL304335A1 (en) 1995-01-23
NO306597B1 (no) 1999-11-29
JPH0753376A (ja) 1995-02-28
AU673747B2 (en) 1996-11-21
RU94026084A (ru) 1996-08-27
MX9405209A (es) 1995-01-31
CZ288593B6 (cs) 2001-07-11
ZA945236B (en) 1995-02-28
ES2138017T3 (es) 2000-01-01
US5356910A (en) 1994-10-18
RU2164795C2 (ru) 2001-04-10
DE69421457D1 (de) 1999-12-09
NO942695L (no) 1995-01-20
DE69421457T2 (de) 2000-05-04
EP0635269B1 (en) 1999-11-03
DK0635269T3 (da) 2000-04-25
HU9402124D0 (en) 1994-09-28
ATE186215T1 (de) 1999-11-15
KR100325276B1 (ko) 2002-09-25

Similar Documents

Publication Publication Date Title
HU9600834D0 (en) Quinazoline derivatives
NO985711D0 (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
NO2005019I2 (no) Metylaminolevulinat, eventuelt i form av et salt, fortrinnsvis metylaminolevulinat-hydroklorid
AP9701041A0 (en) Pyridylpyrrole compounds.
MXPA04000278A (es) Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales.
WO1997005862A3 (en) Use of basic amino acids and derivatives for lowering ceramide levels
NO306597B1 (no) Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament
CA2282279A1 (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
DK557189D0 (da) 1,2,3,4-tetrahydro-1,9-acridindiaminer, deres fremstilling og anvendelse som laegemidler
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
MX9709396A (es) Derivados de fenoxipiperazina para el tratamiento de transtornos del sistema dopamina.

Legal Events

Date Code Title Description
MK1K Patent expired